Thus, the evaluation of beta cell secretion should include, besides insulin and C peptide serum levels, proinsulin, that provides valuable information on the location of the insulin-secreting defect and the progressive or regressive course of the pathogenic process in T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.